1034046-79-1Relevant academic research and scientific papers
The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization
Chobanian, Harry R.,Guo, Yan,Liu, Ping,Lanza Jr., Thomas J.,Chioda, Marc,Chang, Linda,Kelly, Theresa M.,Kan, Yanqing,Palyha, Oksana,Guan, Xiao-Ming,Marsh, Donald J.,Metzger, Joseph M.,Raustad, Katie,Wang, Sheng-Ping,Strack, Alison M.,Gorski, Judith N.,Miller, Randy,Pang, Jianmei,Lyons, Kathy,Dragovic, Jasminka,Ning, Jian G.,Schafer, Wes A.,Welch, Christopher J.,Gong, Xiaoyi,Gao, Ying-Duo,Hornak, Viktor,Reitman, Marc L.,Nargund, Ravi P.,Lin, Linus S.
scheme or table, p. 2845 - 2849 (2012/07/01)
Bombesin receptor subtype 3 (BRS-3) is an orphan G-protein coupled receptor expressed primarily in the hypothalamus which plays a role in the onset of both diabetes and obesity. We report herein our progress made towards identifying a potent, selective bo
SUBSTITUTED DIAZEPINE SULFONAMIDES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS
-
Page/Page column 146, (2010/11/03)
Certain novel substituted diazepine sulfonamides are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.
